Roselabs Finance
22.03
-1.15(-4.96%)
Market Cap₹22.05 Cr
PE Ratio-74.77
Company Performance:
1D-4.96%
1M+0.50%
6M+4.46%
1Y-26.25%
5Y0.00%
View Company Insightsright
More news about Roselabs Finance
29May 26
Roselabs Finance re-appoints Raghava Reddy Balineni as MD for 5 years
Roselabs Finance has approved the re-appointment of Mr. Raghava Reddy Balineni as Managing Director for a term of five years effective May 31, 2026, pending shareholder approval. Mr. Balineni brings over three decades of experience in taxation and general management, having previously led indirect taxation at Lodha Group, ArcelorMittal Nippon Steel India Limited, and Essar Group.
 no imag found
17Apr 26
Roselabs Finance Publishes Audited Financial Results in Newspapers for FY26
Roselabs Finance Limited completed newspaper publication of its FY26 audited financial results in Financial Express and Mumbai Lakshadeep as per SEBI regulations. The company reported revenue growth to ₹120.75 lakhs but sustained losses of ₹30.70 lakhs, with results approved by the Board on April 16, 2026.
 no imag found
16Apr 26
Roselabs Finance Limited Board Meeting held on April 16, 2026 approving appointment of statutory and secretarial auditors under Regulation 30
Roselabs Finance Limited announced auditor appointments at its April 16, 2026 board meeting, appointing Walker Chandioke & Co., LLP as statutory auditors for five consecutive years and Shravan A. Gupta & Associates as secretarial auditors for FY 2026-27, both subject to shareholder approval.
 no imag found
20Jan 26
Roselabs Finance Q3FY26 Results: Loss Narrows to ₹3.67 Crores, Revenue Reaches ₹120.75 Crores
Roselabs Finance Limited reported improved Q3FY26 results with net loss narrowing to ₹3.67 crores from ₹10.84 crores in Q3FY25, while generating revenue of ₹120.75 crores. Nine-month performance showed net loss reduction to ₹14.33 crores from ₹24.63 crores year-on-year. The company's proposed merger with Lodha Developers Limited received BSE approval, with NCLT filing in progress.
 no imag found
17Oct 25
Roselabs Finance Limited Approves Q2 and H1 FY2026 Unaudited Financial Results
Roselabs Finance Limited's Board of Directors approved unaudited financial results for Q2 and H1 FY2026 on October 17, 2025. The meeting lasted from 3:30 p.m. to 3:45 p.m. IST. MSKA & Associates, the statutory auditors, provided an unmodified opinion in their Limited Review Report. The results, covering the period ended September 30, 2025, were submitted to BSE Limited and made available on the company's website, adhering to SEBI regulations.
 no imag found
Roselabs Finance
22.03
-1.15
(-4.96%)
1 Year Returns:-26.25%
Industry Peers
Algoquant Fintech
64.61
(+1.05%)
Gyftr
175.73
(-5.17%)
Prime Securities
283.05
(+2.28%)
RNFI Services
339.55
(+0.21%)
Stellant Securities
1,009.95
(-0.49%)
Kalind
5.78
(-4.15%)